We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Milton Capital Plc | LSE:MII | London | Ordinary Share | GB00BMWLC750 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.575 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 0.575 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 08/10/2024 | 07:02 | UK RNS | Milton Capital PLC Potential Acquisition & Suspension of Listing |
| 08/10/2024 | 06:30 | UK RNS | Official List Suspension - Milton Capital Plc |
| 17/9/2024 | 06:00 | UK RNS | Milton Capital PLC Interim results for the period ended 31 July 2024 |
| 25/7/2024 | 11:32 | UK RNS | Milton Capital PLC Result of AGM |
| 12/7/2024 | 20:28 | ALNC |  IN BRIEF: Milton Capital directors buy total 3.5 million shares |
| 12/7/2024 | 06:00 | UK RNS | Milton Capital PLC Holding(s) in Company |
| 12/7/2024 | 06:00 | UK RNS | Milton Capital PLC Directors Dealings |
| 01/7/2024 | 07:21 | UK RNS | Milton Capital PLC Notice of AGM |
| 31/5/2024 | 18:00 | ALNC | EARNINGS AND TRADING: CT UK High Income tops benchmark, ups dividend |
| 31/5/2024 | 06:00 | UK RNS | Milton Capital PLC ACCOUNTS TO 31 JANUARY 2024, DIRECTOR CHANGES |
Milton Capital (MII) Share Charts1 Year Milton Capital Chart |
|
1 Month Milton Capital Chart |
Intraday Milton Capital Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 31/10/2023 | 11:19 | Milton Capital | 24 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 31/10/2023 11:19 by hedgehog 100 LSE % Gainers Top ListsEPIC Name % HUI Hydrogen Utopia +56% RGD Real Good Food +50% MII Milton Capital +48% OBI Ondine Biomedical +31% PXEN Prospex Energy +12% Yes Solarno. MII are up 48.3% today, rising 0.35p to 1.075p (1p - 1.15p), third on the top risers board. Coincidentally, PXEN are fifth top riser. |
Posted at 20/10/2023 15:16 by hedgehog 100 20/10/2023 15:16 UK Regulatory (RNS & others) Milton Capital PLC Half-year Report LSE:MII Milton Capital Plc"Unaudited interim results for the period ended 31 July 2023 Milton Capital Plc ("Milton" or the "Company") is pleased to announce its interim results for the six months ending 31 July 2023 ("The Period"). The Interims Report will shortly be available to view on the Company's website. Milton is a company incorporated and registered in England and Wales under the Companies Act 2006 and is a SPAC listed on the Standard segment of the London Stock Exchange. Milton was formed with the intention to identify and acquire a suitable business opportunity or opportunities and undertake an acquisition or merger or a series of acquisition or mergers. These Interim results have not been audited or reviewed by the Company's auditors. Highlights: -- The Company recorded a loss before tax of GBP33,841 and had cash balances of GBP910,589 at the end of the period. -- Search for a suitable acquisition target continues. Enquiries Peterhouse Capital Limited Financial Adviser Guy Miller Tel: +44 (0) 20 7469 0930 Corporate Broker Lucy Williams/ Duncan Vasey Tel: +44 (0) 20 7469 0930 CHAIRMAN'S STATEMENT The past half-year has presented challenges in the capital markets due to the upward trend in interest rates, leading to a general slowdown in markets. The heightened uncertainties have made investors exercise caution, impacting our ability to identify a suitable RTO (Reverse Takeover) candidate. Nevertheless, we are confident in the Company's long-term prospects, and we are actively exploring all avenues to create shareholder value. During this period, we are committed to cost-efficiency, as we persist in our quest for a suitable acquisition target. Further updates regarding our acquisition search process will be provided in due time. Malcolm Burne Executive Director Chairman Responsibility Statement We confirm that to the best of our knowledge: -- the Interim Report has been prepared in accordance with International Accounting Standards 34, Interim Financial Reporting, as adopted by the EU. -- gives a true and fair view of the assets, liabilities, financial position and profit/loss of the Group. -- the Interim Report includes a fair review of the information required by DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the set of interim financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year. -- the Interim Report includes a fair review of the information required by DTR 4.2.8R of the Disclosure and Transparency Rules, being the information required on related party transactions. -- The Interim Report was approved by the Board of Directors and the above responsibility statement was signed on its behalf by: Eran Zucker Non-Executive Director 20 October 2023 ..." |
Posted at 23/8/2023 20:17 by hedgehog 100 The shell company ASHI floated at 3p per share in June, market cap. £1.841M., compared to net cash of £717K., including its net IPO proceeds.That didn't look cheap, but to its credit it has suspended (at 2.75p) for a RTO, valued at well over £100M., just two and a half months later:- 06/06/2023 08:01 UK Regulatory (RNS & others) Ashington Innovation PLC Ashington - Admission to trading on the LSE LSE:ASHI Ashington Innovation Plc "Admission to trading on the London Stock Exchange Ashington Innovation plc, a special purpose acquisition company ("SPAC") aiming to benefit from favourable price conditions for companies in the financial services technology (fintech) and deep technology (deep tech) sectors, is pleased to announce that its entire issued ordinary share capital, consisting of 61,397,900 ordinary shares, was admitted to the Standard Listing Segment of the Official List of the Financial Conduct Authority, and to trading on the London Stock Exchange's Main Market for listed securities at 8.00 a.m. today, under the ticker "ASHI". ... About Ashington Innovation plc Ashington Innovation PLC is a special purpose acquisition company (SPAC), formed with the intention of acquiring businesses operating in the technology sector, in particular the financial services technology and deep technology sectors. The Company believes that in the increasingly fast-changing global environment there will be an abundance of opportunities to acquire existing businesses in the technology sector, and in particular businesses that possess and utilise proprietary technologies and own applicable intellectual property. The Company is not limited to any specific geographic region in identifying its target companies. Both Jason Drummond and Jason Smart, directors of the Company, bring a wealth of experience in founding and building successful companies across a diverse range of sectors. www.ashingtoninnovat 17/08/2023 08:10 UK Regulatory (RNS & others) Ashington Innovation PLC Heads of Terms Signed LSE:ASHI Ashington Innovation Plc "Heads of Terms Signed Proposed Reverse Takeover of Cell Therapy Limited Suspension of Listing Conditional Acquisition of Cell Therapy Limited Ashington Innovation (LSE:ASHI), the Special Purpose Acquisition Company (SPAC) established to acquire businesses primarily in the technology sector, is pleased to announce that the Company has entered into a non-binding term sheet (the "Term Sheet") with Cell Therapy Limited ("Cell Therapy") pursuant to which Ashington Innovation will acquire 100% of the total issued equity for GBP135 million in an all share transaction (the "Transaction"). Cell Therapy is a clinical stage biotechnology firm with a portfolio of patented cellular medicines with a lead program that successfully completed an early-stage human clinical trial in heart failure. The Directors of Ashington Innovation consider the Transaction to represent a transformational, value enhancing transaction for shareholders, which is fully aligned with the Company's growth strategy. Cell Therapy's product and patent portfolio provides a platform to develop leading medicines, which have been validated in a human clinical trial and through granted patents in the US, UK, EU and Asia. To fund the Transaction, Ashington Innovation will be seeking to carry out a placing of new ordinary shares to new and existing investors ("Placing") to raise funds of up to GBP3 million to finance the drug development program and working capital. As such, the Transaction is conditional, inter alia, on the completion of due diligence, definitive sale and purchase documentation, obtaining the necessary regulatory approvals from the FCA and the Takeover Panel, a successful Placing, and the passing of necessary resolutions to approve the Transaction by the shareholders of the Company at a duly convened general meeting. Suspension of Listing As the proposed acquisition, if it proceeds, will constitute a Reverse Takeover under the Listing Rules, the Company's ordinary shares shall be suspended pending the publication of a prospectus or an announcement that the proposed Transaction is not proceeding. Any restoration of the listing is subject to the approval of the FCA. At this stage, there can be no guarantee that the proposed Transaction will complete nor as to the final terms of the proposed Transaction. Further announcements and updates will be made in due course. Jason Smart, Founder of Ashington Innovation, commented: "We are delighted to have agreed a heads of terms to acquire Cell Therapy. During the past few months, we have reviewed numerous projects and believe the proposed acquisition meets our stated objective of identifying a potentially extremely valuable entity capable of sustainable development and with significant technological advantages. The directors believe that the regenerative medicine and biotechnology sector presents compelling opportunities to create value for shareholders and the proposed acquisition presents a high-quality target with an experienced and expert leadership. This is a very exciting opportunity to bring a scalable business with a strong track record to the public markets." " Ashington Innovation (ASHI):- This shows the enormous upside of MII, a shell which like ASHI is targeting some extremely cutting edge areas. But at just 0.8p (market cap. £800K.), MII is trading at under half the market cap. of ASHI's, despite having more cash than ASHI: indeed actually trading at below the level of its current cash, which is very unusual for a shell. |
Posted at 11/8/2023 17:22 by hedgehog 100 And no MII trade or volume showing for today.Which I think makes the MII fall yesterday a clear-cut case of 'silly games' from the market makers. Of course they may be hoping that a much wider spread (at the moment) puts off buyers. Though it doesn't have to. Most shells are illiquid: but you can buy them with the intention of holding through suspension for the RTO. After that, a £1M. market cap. can be transformed overnight into a £100M. market cap., and liquidity can follow suit. But not all shell investors have that sort of sense and discipline, which is why you can get such significant shell undervaluations: if MII wasn't so illiquid, then it wouldn't be so cheap. |
Posted at 10/8/2023 13:20 by hedgehog 100 Recent Share Trades for Milton Capital (MII)Date Time Trade Prc Volume Buy/Sell Bid Ask Value 10-Aug-23 13:43:37 0.89 54,668 Buy* 0.70 0.90 486.55 O Interesting MII share price movement today, following today's bullish 7a.m. RNS. The market makers opened the stock down 8.57% at 0.8p mid price, by dropping the bid price to 0.7p from 0.85p; though the ask price is unchanged at 0.9p, and there has been just one modest trade so far today: a buy for 0.89p. So is there a worked sell in the background, or is it just mm games in light of a severe stock shortage? Let's see what shows at the end of today, or tomorrow. |
Posted at 09/8/2023 19:12 by hedgehog 100 Recent Share Trades for Milton Capital (MII)Date Time Trade Prc Volume Buy/Sell Bid Ask Value 09-Aug-23 10:26:30 0.895 1,000,000 Unknown* 0.85 0.90 8,950 O 09-Aug-23 09:22:19 0.895 500,000 Buy* 0.85 0.90 4,475 O Two relatively large MII buys today, both for near the full asking price of 0.9p. 1.5M. shares traded is the second largest share trading day in MII's history; and accounts for 1.5% of MII's shares in issue. Coming so soon after the AGM this looks like a very bullish signal, and suggests that something very big and exciting could be happening here imminently. With this buying recently the market makers must surely be just about out of stock, and anything below the IPO price of a penny looks dirt cheap. So at just 0.875p MII looks like a supremely compelling buy opportunity. |
Posted at 07/8/2023 13:28 by hedgehog 100 MII's AGM was held in London today, at 11a.m.Shortly afterwards, someone bought 250,000 MII shares (incorrectly showing as a sell at just below mid):- Recent Share Trades for Milton Capital (MII) Date Time Trade Prc Volume Buy/Sell Bid Ask Value 07-Aug-23 12:54:24 0.87 250,000 Sell* 0.85 0.90 2,175 O It could be that someone liked what they heard at the AGM, with regard to RTO prospects. And this shell certainly has the potential for a very attractive RTO deal, in the near term, at a large premium (current share price 0.875p). |
Posted at 03/8/2023 17:08 by hedgehog 100 30/01/2023 15:50 UK Regulatory (RNS & others) Milton Capital PLC Holding(s) in Company LSE:MII Milton Capital Plc"... 3. Details of person subject to the notification obligation (iv) Name Flare Capital ... Resulting situation on the date on which threshold was crossed or reached 3.25% 3,250,000 ..." I wonder if today's MII trades have anything to do with Flare Capital, who reported a notifiable interest in MII in January? Either way, FC are an impressive MII shareholder, who could be very useful with American contacts:- |
Posted at 03/8/2023 16:52 by hedgehog 100 Recent Share Trades for Milton Capital (MII)Date Time Trade Prc Volume Buy/Sell Bid Ask Value 03-Aug-23 16:35:24 0.85 30,000 Sell* 0.85 0.90 255.00 UT 03-Aug-23 13:47:40 0.85 5,000,100 Sell* 0.85 0.90 42.50k O 03-Aug-23 13:48:39 0.85 5,000,100 Sell* 0.85 0.90 42.50k O 03-Aug-23 13:47:40 0.085 -5,000,100 Unknown* 0.85 0.90 -4,250 O 03-Aug-23 13:47:40 0.085 5,000,100 Sell* 0.85 0.90 4,250 O Some interesting MII trades today, ahead of the AGM on Monday (7th. August). With 100 million MII shares in issue, a trade of over five million shares represents over 5% of MII's equity. And today's MII trading volume is by far the highest in the company's history. |
Posted at 25/6/2023 11:37 by hedgehog 100 Poor stock market conditions tend to make it harder to IPO, increasing the attractions of the RTO route, and increasing the bargaining power of shells like MII.And meanwhile, the valuations of RTO targets for shells tend to be depressed. So ironically, the s.p.s of shells like MII can become depressed at the same time as they are in effect becoming more valuable: more capable of cutting a cracking RTO deal on great terms - i.e. a better shell valuation and lower target valuation, and great quality targets. Which makes a shell like MII - with both great cash underpinning and great deal prospects - a great place to 'park funds' at the moment. Many investors may wish to reduce their exposure to shares in companies with trading businesses, but holding cash for months doesn't give any real direct upside - certainly in the short term. MII though has both underpinning, and great potential upside. And you don't have to worry about funds being tied up here for a while if you won't be using them anyway. 28/04/2023 15:15 UK Regulatory (RNS & others) Milton Capital PLC Annual Financial Report LSE:MII Milton Capital Plc " ... Milton Capital Plc - Chairman's Statement for the period ended 31 January 2023 Dear Shareholders, The board of Milton Capital Plc is pleased to present its inaugural Annual Report to shareholders. I am delighted to announce that our cash shell with a focus on technology has successfully completed its listing on the London Stock Exchange on 4th October 2022, and we are now officially a public company. This marks an important milestone for our business and opens up new opportunities for us to create value for our shareholders. As a cash shell, our primary objective is to identify and invest in attractive businesses or assets that have the potential to generate strong returns for our investors. With our focus on technology, we are particularly interested in high-growth sectors such as AI, edge computing, quantum computing, machine learning, automation, robotics, blockchain, nanomaterials and the exploitation of space. We believe that the rapid pace of technological change and disruption presents significant opportunities for value creation, and we will be actively seeking out innovative businesses and technologies that have the potential to generate significant returns for our shareholders. Our experienced management team has a proven track record of identifying and executing successful investments, and we believe that our team's expertise and network will be a key advantage as we seek out new investment opportunities in the technology sector. We will continue to be guided by our core principles of integrity, transparency, and accountability as we navigate the investment landscape and evaluate potential investments in the technology space. We believe that building strong relationships with our investors is essential to our success as a public company, and we are committed to earning and maintaining your trust. We are also committed to maintaining open and transparent communication with our shareholders, and we will provide regular updates on our progress and any material developments. It is important to us that our shareholders have a clear understanding of our strategy and investment approach, and we will be as forthcoming as possible with information that is relevant to our performance. It is worth noting that this statement has been drafted by ChatGPT, a language model trained by OpenAI, but it has been reviewed and approved by our management team to ensure that it accurately reflects our vision and objectives. Our commitment to technology extends beyond just investing in innovative businesses and assets. As evidenced by our use of ChatGPT to draft this statement, we are constantly exploring new and emerging technologies that can help us achieve our objectives more efficiently and effectively. We believe that our use of cutting-edge technology reflects the ethos of our company and our dedication to remaining at the forefront of technological advancement. We are committed to leveraging technology in all areas of our business to drive growth and create value for our shareholders. In conclusion, I would like to thank our shareholders for their support and confidence in our business. We are excited about the opportunities that lie ahead in the dynamic and rapidly evolving technology sector, and look forward to delivering value for our shareholders as we embark on this new chapter in our journey. Sincerely, Eran Zucker Non-Executive Director 28 April 2023 ... Investing policy Milton Capital Plc was formed with the intention to identify and acquire a suitable business opportunity or opportunities and undertake an acquisition or merger or a series of acquisitions or mergers. The Company intends the main focus of the acquisition strategy to be on the technology sector, in particular: edge computing, quantum computing, artificial intelligence, machine learning, automation, robotics, blockchain, nanomaterials and the exploitation of space. The Directors see these technologies as having considerable growth potential for the foreseeable future and many of the prospects they have identified are in this sector. The Directors believe that any acquisition target will have at least one of four key components: (i) a strong management team; (ii) an innovative product proposal (iii) revenue enhancing or cost saving capabilities; and (iv) high growth potential. It is anticipated that the main driver of success for the Company will be its focus, during the investment screening process, on the management involved in the potential target companies and the potential value creation that the team of people is capable of realising. The Company intends to own, operate and manage the target acquisitions. Accordingly, where the Directors feel that a target company would benefit from their skills and expertise, they may look to seek representation on the board of the target company. The Directors believe that their broad, collective experience, together with their extensive network of contacts, will assist them in identifying, evaluating and funding suitable acquisition opportunities. ..." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
